ITU – XPRIZE Inaugural AI for Good Summit Takes Place in Geneva

ITU – XPRIZE Inaugural AI for Good Summit Takes Place in Geneva
Invited Speaker Barry Ressler, Chairman & CEO of ISMC, discusses the use and challenges of Artificial Intelligence for Citizen Health and Medical Ethics

Geneva, Switzerland, (June 7-9, 2017) ISMC Chairman and CEO Barry Ressler took part in the United Nations International Telecommunication Union (ITU) – XPRIZE inaugural Summit on Artificial Intelligence for Good as an invited speaker. The groundbreaking event brought together policymakers, industry leaders, financial institutions, academia and civil society from both developed and developing countries, as well as United Nations agencies, to discuss the role Artificial Intelligence (AI) can play in solving humanity’s biggest challenges. Special attention was given to how AI can be used to help achieve the United Nations’ Sustainable Development Goals.

The three-day summit, whose opening speakers included Houlin Zhao, Secretary-General of the ITU and Marcus Shingles, CEO of the XPRIZE Foundation, provided an excellent forum for debate on the importance and future of AI solutions in addressing global issues like hunger, poverty, health and the environment. Mr Ressler highlighted some significant AI applications under development by ISMC, focused on education, space medicine, and food/agriculture. He focused on diagnosing the speciation and state of viral, bacterial, fungi, spore and amoeba pathogens at the early stage of an outbreak based on patented algorithms and empirically proven dynamic modeling and simulation to be machine learned by an AI platform. This is not to treat patients but to mitigate the source of infection. The objective is to offset a remote, out of control epidemic/pandemic. The technology and systems that we are developing for Low earth Orbit conditions and eventually interplanetary colonization is about as remote as you can get compared to isolated remote locations on earth. Mr. Ressler further commented on the critical need to address antimicrobial resistance, a priority area shared by the World Health Organization (WHO).

ISMC was also represented at the meeting by COO Steve Diamond, and Fabrizio Gramuglio, CEO of their affiliate company Forever Identity and John Vickers, Managing Director of their partner project company Blue Abyss, an enterprise aiming to build a premier aquatic and space extreme environment research, development and training facility in the UK. Mr Ressler was joined on the Artificial Intelligence for Citizen Health and Medical Ethics panel by Abha Saxena, Coordinator of Global Health Ethics for the World Health Organization (WHO), Jay Komarneni, Founder & Chair of the Human Diagnosis Project, and Christiane Woopen, Professor of Ethics and Theory of Medicine, University of Cologne, in what was an excellent opportunity to build and strengthen networks with respected innovators in the field of AI.

The panel was moderated by Mohamed Alkady, the president of Hart, a medical technology company that’s improving the ways in which people inside and outside of the industry access and engage with health data.

About ISMC, Inc.
ISMC is committed to advancing the state-of-the-art in the innovative field of space medicine and to collaborate with leading space communities and organizations in the exciting area of human space exploration. It further aims to connect space exploration and humanity by pioneering space medicine technologies and applications. This commitment will position ISMC in support of future international human spaceflight missions and the emerging commercial space tourism industry.

Contact:
International Space Medicine Consortium Inc.
Phone: USA +1-202-429-8439
info@spacemedicineconsortium.com